JAMA Neurology Publishes Landmark Study Showing Neuropacs™ AI Technology Significantly Enhances the Diagnostic Accuracy of Parkinson’s Disease and Atypical Parkinsonism
UF startup neuropacs™ Corp., a leading innovator in AI-driven neurological diagnostics, announces the results of a prospective multicenter study that evaluated neuropacs™ AI technology for diagnosing Parkinson’s disease and atypical parkinsonism.
